Social enterprise, Lucky Iron Fish, completes Series A Funding with a new investment from Danone Communities to better help address iron deficiency
25 oct. 2021 07h50 HE
|
Lucky Iron Fish
Toronto, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Toronto, ON (Oct 22, 2021) — Lucky Iron Fish Enterprise (LIFe) is pleased to announce the completion of a $1 Million Series A funding, led by Danone...
ObsEva to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
07 sept. 2021 01h00 HE
|
ObsEva SA
GENEVA, Switzerland September 7, 2021 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...
Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed
20 juil. 2021 08h31 HE
|
Femasys Inc.
First in Class Insemination Treatment for Infertility LOCAL Pivotal Trial to Enroll Up to 792 Patients Across 20 U.S. Centers ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:...
Lucky Iron Fish receives $250k in funding to help address iron deficiency anemia in Benin.
30 juin 2021 12h32 HE
|
Lucky Iron Fish
Toronto, June 30, 2021 (GLOBE NEWSWIRE) -- Lucky Iron Fish Enterprise (LIFe) is an impact-driven company that is on a mission to tackle iron deficiency globally using their innovative solutions...
Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
19 févr. 2021 08h35 HE
|
Agile Therapeutics, Inc.
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will...
Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories
17 mai 2019 08h30 HE
|
Bio-Reference Laboratories
Elmwood Park, NJ, May 17, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health company, along with its specialty women’s health division, GenPath, today announces the launch of...
BioReference Laboratories to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions
02 mai 2019 17h05 HE
|
Bio-Reference Laboratories
Elmwood Park, NJ, May 02, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new...
Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition
14 mars 2018 07h45 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women's healthcare company today announced that an abstract related to the Phase 3 SECURE study for...
Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
12 mars 2018 16h15 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, today reported financial results for the three months and year ended...
Sona Jasani, MD is Honored by the American Health Council for “Best in Medicine”
14 févr. 2018 08h00 HE
|
American Health Council
NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- The American Health Council is honored to name Sona Jasani, MD as one of “America’s Best Doctors” for her unparalleled professional dedication and...